Do you want to read an article? Please log in or register.
The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD
Tuberculosis
RECOMMENDED
Related content
RECOMMENDED
Tuberculosis
Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Nat Commun
Walter ND, Born SEM, Robertson GT, Reichlen M, Dide-Agossou C, Ektnitphong VA, Rossmassler K, Ramey ME, Bauman AA, Ozols V, Bearrows SC, Schoolnik G, Dolganov G, Garcia B, Musisi E, Worodria W, Huang L, Davis JL, Nguyen NV, Nguyen HV, Nguyen ATV, Phan H, Wilusz C, Podell BK, Sanoussi ND, de Jong BC, Merle CS, Affolabi D, McIlleron H, Garcia-Cremades M, Maidji E, Eshun-Wilson F, Aguilar-Rodriguez B, Karthikeyan D, Mdluli K, Bansbach C, Lenaerts AJ, Savic RM, Nahid P, Vásquez JJ, Voskuil MI
doi: 10.1038/s41467-021-22833-6
RECOMMENDED
Tuberculosis
Use of a Whole Genome Sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017-2019: an ECDC pilot study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J.
Tagliani E, Anthony R, Kohl TA, de Neeling A, Nikolayevskyy V, Ködmön C, Maurer FP, Niemann S, van Soolingen D, van der Werf MJ, Cirillo DM, ECDC molecular surveillance project participants
doi: 10.1183/13993003.02272-2020.
Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis
N Engl J Med.
Xie YL, Chakravorty S, Armstrong DT, Hall SL, Via LE, Song T, Yuan X, Mo X, Zhu H, Xu P, Gao Q, Lee M, Lee J, Smith LE, Chen RY, Joh JS, Cho Y, Liu X, Ruan X1, Liang L, Dharan N, Cho SN, Barry CE 3rd, Ellner JJ, Dorman SE, Alland D
doi: 10.1056/
RECOMMENDED
Tuberculosis
Plasma membrane damage causes NLRP3 activation and pyroptosis during Mycobacterium tuberculosis infection
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Nat Commun.
Beckwith KS, Beckwith MS, Ullmann S, Sætra RS, Kim H, Marstad A, Åsberg SE, Strand TA, Haug M, Niederweis M, Stenmark HA, Flo TH
doi: 10.1038/s41467-020-16143-6.
RECOMMENDED
TuberculosisFurther Publications
Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study
Lancet Infect Dis.
Berrocal-Almanza LC, Harris R, Lalor MK, Muzyamba MC, Were J, O'Connell AM, Mirza A, Kon OM, Lalvani A, Zenner D
doi: 10.1016/S1473-3099(19)30260-9.
Tuberculosis
Optimizing and accelerating the assignation of lineages in Mycobacterium tuberculosis using novel alternative single-tube assays
PLoS One.
Carcelén M, Abascal E, Herranz M, Santantón S, Zenteno R, Ruiz Serrano MJ, Bouza E, Pérez-Lago L, García-de-Viedma D
doi: 10.1371/journal.
Tuberculosis
Toxin-mediated ribosome stalling reprograms the Mycobacterium tuberculosis proteome
Nat Commun.
Barth VC, Zeng JM, Vvedenskaya IO, Ouyang M, Husson RN, Woychik NA
doi: 10.1038/s41467-019-10869-8.
RECOMMENDED
Tuberculosis
Management of active tuberculosis in adults with HIV
Lancet HIV.
Meintjes G, Brust JCM, Nuttall J, Maartens G
doi: 10.1016/S2352-3018(19)30154-7.
RECOMMENDED
Tuberculosis
Optimising pyrazinamide for the treatment of tuberculosis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Zhang N, Savic RM, Boeree MJ, Peloquin C, Weiner M, Heinrich N, Bliven-Sizemore E, Phillips PP, Hoelscher M, Whitworth W, Morlock G, Posey J, Stout JE, Mac Kenzie W, Aarnoutse R, Dooley KE, Tuberculosis Trials Consortium (TBTC) and Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA) Networks.
doi: 10.1183/13993003.02013-2020